Gastroenterology and Endoscopy Unit, Dupuytren University Hospital, Limoges 87000, France.
Department of Hepatology and Gastroenterology, Clermont-Ferrand University Hospital, Clermont-Ferrand 63000, France.
World J Gastroenterol. 2023 Jun 14;29(22):3548-3560. doi: 10.3748/wjg.v29.i22.3548.
Non-alcoholic fatty liver disease (NAFLD) is becoming a major health problem, resulting in hepatic, metabolic and cardio-vascular morbidity.
To evaluate new ultrasonographic tools to detect and measure hepatic steatosis.
We prospectively included 105 patients referred to our liver unit for NAFLD suspicion or follow-up. They underwent ultrasonographic measurement of liver sound speed estimation (SSE) and attenuation coefficient (AC) using Aixplorer MACH 30 (Supersonic Imagine, France), continuous controlled attenuation parameter (cCAP) using Fibroscan (Echosens, France) and standard liver ultrasound with hepato-renal index (HRI) calculation. Hepatic steatosis was then classified according to magnetic resonance imaging proton density fat fraction (PDFF). Receiver operating curve (ROC) analysis was performed to evaluate the diagnostic performance in the diagnosis of steatosis.
Most patients were overweight or obese (90%) and had metabolic syndrome (70%). One third suffered from diabetes. Steatosis was identified in 85 patients (81%) according to PDFF. Twenty-one patients (20%) had advanced liver disease. SSE, AC, cCAP and HRI correlated with PDFF, with respective Spearman correlation coefficient of -0.39, 0.42, 0.54 and 0.59 ( < 0.01). Area under the receiver operating characteristic curve (AUROC) for detection of steatosis with HRI was 0.91 (0.83-0.99), with the best cut-off value being 1.3 (Se = 83%, Sp = 98%). The optimal cCAP threshold of 275 dB/m, corresponding to the recent EASL-suggested threshold, had a sensitivity of 72% and a specificity of 80%. Corresponding AUROC was 0.79 (0.66-0.92). The diagnostic accuracy of cCAP was more reliable when standard deviation was < 15 dB/m with an AUC of 0.91 (0.83-0.98). An AC threshold of 0.42 dB/cm/MHz had an AUROC was 0.82 (0.70-0.93). SSE performed moderately with an AUROC of 0.73 (0.62-0.84).
Among all ultrasonographic tools evaluated in this study, including new-generation tools such as cCAP and SSE, HRI had the best performance. It is also the simplest and most available method as most ultrasound scans are equipped with this module.
非酒精性脂肪性肝病(NAFLD)正成为一个主要的健康问题,导致肝脏、代谢和心血管发病率。
评估新的超声工具来检测和测量肝脂肪变性。
我们前瞻性地纳入了 105 例因怀疑或随访非酒精性脂肪性肝病而被转至我院肝脏科的患者。他们接受了 Aixplorer MACH 30(Supersonic Imagine,法国)肝声速估计(SSE)和衰减系数(AC)的超声测量,Fibroscan(Echosens,法国)的连续控制衰减参数(cCAP)和标准肝超声并计算肝-肾指数(HRI)。然后根据磁共振成像质子密度脂肪分数(PDFF)对肝脂肪变性进行分类。进行受试者工作特征曲线(ROC)分析以评估诊断性能。
大多数患者超重或肥胖(90%),有代谢综合征(70%)。三分之一的患者患有糖尿病。根据 PDFF,85 例患者(81%)存在脂肪变性。21 例患者(20%)患有晚期肝病。SSE、AC、cCAP 和 HRI 与 PDFF 相关,各自的 Spearman 相关系数为-0.39、0.42、0.54 和 0.59(<0.01)。HRI 检测脂肪变性的受试者工作特征曲线下面积(AUROC)为 0.91(0.83-0.99),最佳截断值为 1.3(Se=83%,Sp=98%)。最近 EASL 建议的 275dB/m 的最佳 cCAP 阈值具有 72%的敏感性和 80%的特异性。相应的 AUROC 为 0.79(0.66-0.92)。当标准偏差<15dB/m 时,cCAP 的诊断准确性更可靠,AUROC 为 0.91(0.83-0.98)。AC 阈值为 0.42dB/cm/MHz,AUROC 为 0.82(0.70-0.93)。SSE 表现中等,AUROC 为 0.73(0.62-0.84)。
在本研究评估的所有超声工具中,包括新一代工具如 cCAP 和 SSE,HRI 的性能最佳。它也是最简单和最可用的方法,因为大多数超声扫描都配备了这个模块。